167 related articles for article (PubMed ID: 35238270)
1.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Xenobiotica; 2022 Feb; 52(2):113-118. PubMed ID: 35238270
[TBL] [Abstract][Full Text] [Related]
2. Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics.
Wambaugh JF; Hughes MF; Ring CL; MacMillan DK; Ford J; Fennell TR; Black SR; Snyder RW; Sipes NS; Wetmore BA; Westerhout J; Setzer RW; Pearce RG; Simmons JE; Thomas RS
Toxicol Sci; 2018 May; 163(1):152-169. PubMed ID: 29385628
[TBL] [Abstract][Full Text] [Related]
3. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
Parrott N; Manevski N; Olivares-Morales A
Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
[TBL] [Abstract][Full Text] [Related]
4. Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.
Dawson DE; Ingle BL; Phillips KA; Nichols JW; Wambaugh JF; Tornero-Velez R
Environ Sci Technol; 2021 May; 55(9):6505-6517. PubMed ID: 33856768
[TBL] [Abstract][Full Text] [Related]
5.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Altern Lab Anim; 2023 Jan; 51(1):39-54. PubMed ID: 36572567
[TBL] [Abstract][Full Text] [Related]
6. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.
Mavroudis PD; Hermes HE; Teutonico D; Preuss TG; Schneckener S
PLoS One; 2018; 13(3):e0194294. PubMed ID: 29561908
[TBL] [Abstract][Full Text] [Related]
8.
Fagerholm U; Hellberg S; Alvarsson J; Arvidsson McShane S; Spjuth O
Xenobiotica; 2021 Dec; 51(12):1366-1371. PubMed ID: 34845977
[TBL] [Abstract][Full Text] [Related]
9. Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs.
Sung JH
Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):969-986. PubMed ID: 33764248
[No Abstract] [Full Text] [Related]
10. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Kosugi Y; Hosea N
Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
[TBL] [Abstract][Full Text] [Related]
11. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
12. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
13. Advances in Predictions of Oral Bioavailability of Candidate Drugs in Man with New Machine Learning Methodology.
Fagerholm U; Hellberg S; Spjuth O
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925103
[TBL] [Abstract][Full Text] [Related]
14. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
Zhang T; Heimbach T; Lin W; Zhang J; He H
J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
[TBL] [Abstract][Full Text] [Related]
15. Drug design tools--in silico, in vitro and in vivo ADME/PK prediction and interpretation: is PK in monkey an essential part of a good human PK prediction?
Hosea NA
Curr Top Med Chem; 2011; 11(4):351-7. PubMed ID: 21320064
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
Pearce RG; Setzer RW; Davis JL; Wambaugh JF
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
[TBL] [Abstract][Full Text] [Related]
17. Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage.
Stoyanova R; Katzberger PM; Komissarov L; Khadhraoui A; Sach-Peltason L; Groebke Zbinden K; Schindler T; Manevski N
J Chem Inf Model; 2023 Jan; 63(2):442-458. PubMed ID: 36595708
[TBL] [Abstract][Full Text] [Related]
18. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
Fagerholm U
Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
[TBL] [Abstract][Full Text] [Related]
19. Comparison between lab variability and
Fagerholm U; Spjuth O; Hellberg S
Xenobiotica; 2021 Oct; 51(10):1095-1100. PubMed ID: 34346291
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of the GastroPlus
Zhang F; Bartels M; Clark A; Erskine T; Auernhammer T; Bhhatarai B; Wilson D; Marty S
SAR QSAR Environ Res; 2018 Nov; 29(11):875-893. PubMed ID: 30286617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
